Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simone Scuderi

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
Cancers|October 27, 2022
A Systematic Review to Evaluate Patient-Reported Outcome Measures (PROMs) for Metastatic Prostate Cancer According to the COnsensus-Based Standard for the Selection of Health Measurement INstruments (COSMIN) MethodologyMaria Monica Ratti, Giorgio Gandaglia, Elena Silvia Sisca, et al.
Prostate Cancer and Prostatic Diseases|June 2, 2025
Tailored use of PSA density according to multiparametric MRI index lesion location: results of a large, multi-institutional seriesLeonardo Quarta, Armando Stabile, Francesco Pellegrino, et al.
Minerva Urology and Nephrology|October 23, 2025
The added value of PSMA PET to nomograms in identifying optimal candidates for extended pelvic lymph node dissection in intermediate-risk prostate cancer patientsMatteo Bauckneht, Enrico Checcucci, Francesco Lanfranchi, et al.
European Urology Oncology|November 17, 2021
Standardising the Assessment of Patient-reported Outcome Measures in Localised Prostate Cancer. A Systematic ReviewMaria Monica Ratti, Giorgio Gandaglia, Eugenia Alleva, et al.
European Urology Open Science|February 20, 2026
Surgical Technique and Perioperative and Postoperative Outcomes for Robot-assisted Radical Cystectomy with Intracorporeal Urinary Diversion Performed with the Hugo RAS Robotic Platform: First Large Case Series by the European Association of Urology Robotic Urology Section Scientific Working GroupSimone Scuderi, Juhana Rautiola, Chiara Sighinolfi, et al.
BMJ Open|April 5, 2022
Diagnostic and prognostic factors in patients with prostate cancer: a systematic reviewKatharina Beyer, Lisa Moris, Michael Lardas, et al.
European Urology Oncology|June 28, 2021
Definition and Impact on Oncologic Outcomes of Persistently Elevated Prostate-specific Antigen After Salvage Lymph Node Dissection for Node-only Recurrent Prostate Cancer After Radical Prostatectomy: Clinical Implications for Multimodal TherapyCarlo A Bravi, Matteo Droghetti, Nicola Fossati, et al.
European Urology Oncology|June 3, 2023
Identification of the Optimal Candidates for Nodal Staging with Extended Pelvic Lymph Node Dissection Among Prostate Cancer Patients Who Underwent Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography. External Validation of the Memorial Sloan Kettering Cancer Center and Briganti Nomograms and Development of a Novel ToolGiorgio Gandaglia, Francesco Barletta, Daniele Robesti, et al.
European Urology Oncology|January 31, 2025
External Validation of Nomograms for the Identification of Pelvic Nodal Dissection Candidates Among Prostate Cancer Patients with Negative Preoperative Prostate-specific Membrane Antigen Positron Emission TomographyGiorgio Gandaglia, Francesco Barletta, Simone Scuderi, et al.
European Urology Open Science|September 12, 2024
Observation With or Without Subsequent Salvage Therapy for Pathologically Node-positive Prostate Cancer With Negative Conventional Imaging: Results From a Large Multicenter CohortGiancarlo Marra, Federico Lesma, Gabriele Montefusco, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Cancers|October 27, 2022
A Systematic Review to Evaluate Patient-Reported Outcome Measures (PROMs) for Metastatic Prostate Cancer According to the COnsensus-Based Standard for the Selection of Health Measurement INstruments (COSMIN) MethodologyMaria Monica Ratti, Giorgio Gandaglia, Elena Silvia Sisca, et al.
Prostate Cancer and Prostatic Diseases|June 2, 2025
Tailored use of PSA density according to multiparametric MRI index lesion location: results of a large, multi-institutional seriesLeonardo Quarta, Armando Stabile, Francesco Pellegrino, et al.
Minerva Urology and Nephrology|October 23, 2025
The added value of PSMA PET to nomograms in identifying optimal candidates for extended pelvic lymph node dissection in intermediate-risk prostate cancer patientsMatteo Bauckneht, Enrico Checcucci, Francesco Lanfranchi, et al.
European Urology Oncology|November 17, 2021
Standardising the Assessment of Patient-reported Outcome Measures in Localised Prostate Cancer. A Systematic ReviewMaria Monica Ratti, Giorgio Gandaglia, Eugenia Alleva, et al.
European Urology Open Science|February 20, 2026
Surgical Technique and Perioperative and Postoperative Outcomes for Robot-assisted Radical Cystectomy with Intracorporeal Urinary Diversion Performed with the Hugo RAS Robotic Platform: First Large Case Series by the European Association of Urology Robotic Urology Section Scientific Working GroupSimone Scuderi, Juhana Rautiola, Chiara Sighinolfi, et al.
BMJ Open|April 5, 2022
Diagnostic and prognostic factors in patients with prostate cancer: a systematic reviewKatharina Beyer, Lisa Moris, Michael Lardas, et al.
European Urology Oncology|June 28, 2021
Definition and Impact on Oncologic Outcomes of Persistently Elevated Prostate-specific Antigen After Salvage Lymph Node Dissection for Node-only Recurrent Prostate Cancer After Radical Prostatectomy: Clinical Implications for Multimodal TherapyCarlo A Bravi, Matteo Droghetti, Nicola Fossati, et al.
European Urology Oncology|June 3, 2023
Identification of the Optimal Candidates for Nodal Staging with Extended Pelvic Lymph Node Dissection Among Prostate Cancer Patients Who Underwent Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography. External Validation of the Memorial Sloan Kettering Cancer Center and Briganti Nomograms and Development of a Novel ToolGiorgio Gandaglia, Francesco Barletta, Daniele Robesti, et al.
European Urology Oncology|January 31, 2025
External Validation of Nomograms for the Identification of Pelvic Nodal Dissection Candidates Among Prostate Cancer Patients with Negative Preoperative Prostate-specific Membrane Antigen Positron Emission TomographyGiorgio Gandaglia, Francesco Barletta, Simone Scuderi, et al.
European Urology Open Science|September 12, 2024
Observation With or Without Subsequent Salvage Therapy for Pathologically Node-positive Prostate Cancer With Negative Conventional Imaging: Results From a Large Multicenter CohortGiancarlo Marra, Federico Lesma, Gabriele Montefusco, et al.
Pageof 7